ANVS ▲ +2.4% - Annovis Bio, Inc. $ANVS - Annovis Announces Partnership with Weave Bio, AI Regulatory Platform, in Preparation of NDA for Buntanetap in Alzheimer’s Disease Annovis Bio rose 2.4% following news of a partnership with Weave Bio, an AI regulatory platform, to support the company's NDA submission process for buntanetap in Alzheimer's disease. The collaboration signals progress toward regulatory approval for the company's lead therapeutic candidate, which likely drove investor optimism. 23-SEP-2026 08:00 AM ET